StonvexLoading…
StonvexCore line items from POR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $863.00M | $3.56B | $2.68B | $1.73B |
Operating Income | $107.00M | $555.00M | $460.00M | $286.00M |
Net Income | $45.00M | $306.00M | $265.00M | $62.00M |
EPS (Diluted) | $0.38 | $2.77 | $2.41 | $1.47 |
Total Assets | $13.20B | $13.23B | $13.01B | $12.68B |
Total Liabilities | $9.08B | $9.10B | $9.06B | $8.83B |
Cash & Equivalents | $8.00M | $76.00M | $137.00M | $56.00M |
Free Cash Flow OCF − CapEx | $9.00M | $-71.00M | $71.00M | $-29.00M |
Shares Outstanding | 115.73M | 115.56M | 110.72M | 109.56M |